Chlorpheniramine / methscopolamine / phenylephrine / pseudoephedrine Pregnancy and Breastfeeding Warnings
Chlorpheniramine / methscopolamine / phenylephrine / pseudoephedrine is also known as: AlleRx Dose Pack
Chlorpheniramine / methscopolamine / phenylephrine / pseudoephedrine Pregnancy Warnings
Chlorpheniramine/methscopolamine/PE/PSE has been assigned to pregnancy category C by the FDA. Animal studies have not been reported. There are no controlled data in human pregnancy. Chlorpheniramine/dextromethorphan/PE/PSE is only recommended for use during pregnancy when benefit outweighs risk.
Chlorpheniramine / methscopolamine / phenylephrine / pseudoephedrine Breastfeeding Warnings
There are no data on the excretion of chlorpheniramine/methscopolamine/PE/PSE into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
References for pregnancy information
- "Product Information. AlleRx Dose Pack (chlorpheniramine/methscopolamine/PE/PSE)." Cornerstone Therapeutics
References for breastfeeding information
- "Product Information. AlleRx Dose Pack (chlorpheniramine/methscopolamine/PE/PSE)." Cornerstone Therapeutics
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.